This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Rochester Medical Director Schnobrich To Retire





STEWARTVILLE, Minn., Dec. 23, 2011 /PRNewswire/ -- Rochester Medical Corporation (Nasdaq: ROCM) announced today that Roger W. Schnobrich will retire from its Board of Directors following the conclusion of the Company's 2012 Annual Meeting of Shareholders to be held on January 26, 2012, which is the end of his current term.

Board Chairman and CEO Anthony J. Conway stated that "Mr. Schnobrich has served on our Board since 1995.  His cheerful intelligence and gracious temperament have served the Company well.  He is a man of excellent character and dignity, and Rochester Medical Corporation has benefited greatly from these traits over the years.

"Our many thanks for working with us, Roger. I know you will continue to enjoy each day."

Conway continued, "I am very pleased to announce that the Board of Directors has nominated Peter H. Shepard for election as a Director for Rochester Medical Corporation at the 2012 Annual Meeting.  Mr. Shepard has deep knowledge and experience in the medical device industry and is particularly expert in the field of Urology and Incontinence.  Mr. Shepard's extensive sales and marketing experience will enable him to provide valuable insight and guidance to our management team with respect to our strategic initiatives to grow sales domestically and internationally."

About Rochester Medical Corporation

Rochester Medical Corporation develops, manufactures, and markets disposable medical catheters and devices for urological and continence care applications.  The Company also sells certain ostomy and wound and scar care products and other brands of urological products into the European marketplace.

For further information, please contact Anthony J. Conway, President and Chief Executive Officer or David A. Jonas, Chief Financial Officer of Rochester Medical Corporation at (507) 533-9600 or Parice Halbert, CFA, at Westwicke Partners (443) 213-0500.  More information about the 2012 Annual Meeting of Shareholders is included in the Company's proxy statement filed with the Securities and Exchange Commission on December 23, 2011.  More information about Rochester Medical is available on its website at http://www.rocm.com.

SOURCE Rochester Medical Corporation

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,162.99 +121.45 0.67%
S&P 500 2,123.48 +19.28 0.92%
NASDAQ 5,106.5930 +73.8420 1.47%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs